文献速递乳房整形与再造

治疗性乳房切除与对侧预防性乳房切除重建并发症比较:配对分析

A Comparison of Complications in Therapeutic versus Contralateral Prophylactic Mastectomy Reconstruction: A Paired Analysis.
PubMed 文献 · Plast Reconstr Surg · 2022-03-02

本研究纳入单中心2009至2019年因单侧乳腺癌行双侧乳房切除(含对侧预防性切除)并自体或植入物重建的130例患者(260侧重建),按侧别配对比较并发症。结果显示治疗侧与预防性侧在重建失败、再手术、皮瓣坏死、血清肿、脂肪坏死、伤口感染和蜂窝织炎的发生率上均无显著差异。

要点

  • 治疗侧与预防性侧重建失败率无显著差异(p=0.57)。
  • 再手术、皮瓣坏死、血清肿、脂肪坏死、伤口感染和蜂窝织炎发生率两侧均无显著差异。
  • 20.0%患者并发症仅见于预防性侧,11.5%仅见于治疗侧。

核心结论

  • 尽管治疗侧有局部放疗史和更广泛的肿瘤手术,双侧重建后治疗侧与对侧预防性乳房切除侧术后并发症发生率无显著差异。

研究设计与样本

  • 单中心识别2009至2019年因单侧乳腺癌行双侧乳房切除并自体或植入物乳房重建的130例患者(260侧重建),按侧别配对分析并发症风险。

主要发现

  • 治疗侧与预防性侧重建失败发生率相似(p=0.57),再手术(p=0.44)、皮瓣坏死(p=0.32)、血清肿(p=0.82)、脂肪坏死(p=0.16)、伤口感染(p=0.56)和蜂窝织炎(p=0.56)发生率均无显著差异。
  • 治疗侧行改良根治性乳房切除并腋窝淋巴结清扫的比例高于对侧预防性乳房切除(15.4% vs 0%)。
  • 44%的患者在确定性重建前完成了治疗侧乳房切除术后放疗。
  • 近五分之一患者并发症仅局限于预防性侧:对侧预防性乳房切除重建并发症26例(20.0%),治疗性乳房切除重建并发症15例(11.5%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although breast reconstruction after bilateral mastectomies including a contralateral prophylactic mastectomy is known to have a higher overall complication profile, whether reconstructive complication rates differ between the therapeutic mastectomy and contralateral prophylactic mastectomy sides remains unclear. METHODS: Women undergoing bilateral mastectomies with autologous or implant-based breast reconstruction for a unilateral breast cancer at a single institution were identified (2009 to 2019). Postoperative complications were stratified by laterality (therapeutic mastectomy versus contralateral prophylactic mastectomy). Paired data were analyzed to compare the risks of complications between prophylactic and therapeutic reconstruction sides in the same patient. RESULTS: A total of 130 patients (260 reconstructions) underwent bilateral autologous or implant-based reconstruction. Although most women underwent a simple mastectomy, a higher proportion of therapeutic mastectomies were modified radical mastectomies including axillary lymph node dissections compared to contralateral prophylactic mastectomies (15.4 percent versus 0 percent). Forty-four percent of women completed postmastectomy radiation therapy of the therapeutic side before definitive reconstruction. Overall, both therapeutic and prophylactic reconstructions had a similar incidence of reconstructive failure (p = 0.57), return to the operating room (p = 0.44), mastectomy skin flap necrosis (p = 0.32), seroma (p = 0.82), fat necrosis (p = 0.16), wound infection (p = 0.56), and cellulitis (p = 0.56). Nearly one-fifth of patients experienced complications limited to the prophylactic side [contralateral prophylactic mastectomy reconstruction complications, n = 26 (20.0 percent); therapeutic mastectomy reconstruction complications, n = 15 (11.5 percent)]. CONCLUSION: Despite a history of local radiation therapy and more extensive oncologic surgery on the therapeutic side, there are no significant differences in the incidence of postsurgical complications on the therapeutic mastectomy and contralateral prophylactic mastectomy sides after bilateral reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Sergesketter AR, Marks C, Broadwater G, et al. A Comparison of Complications in Therapeutic versus Contralateral Prophylactic Mastectomy Reconstruction: A Paired Analysis. Plast Reconstr Surg. 2022. PMID: 35245238. doi:10.1097/PRS.0000000000008981

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。